AmericasENPublic drug registration overview
Mexico Pharmaceutical Registration Pathway
Market Overview Market profile: Mexico is a core Latin American pharmaceutical market. COFEPRIS registration, public procurement, private pharmacy channels, and Spanish labeling ar...
Updated: 2026-05-04
You are viewing the public excerpt. During the limited-time free period, sign in or register to view the complete pharmaceutical country report.
AI Citation Summary
- Country: Mexico Pharmaceutical Registration Pathway
- Product line: Pharmaceuticals
- Regulator / source: Regulatory maturity: Medium-high. COFEPRIS regulates new medicines, generics, biotech products, and imported drugs.
- Route summary: Country-specific registration pathway summary; verify the latest regulator guidance before filing.
- Typical timeline: Varies by product class, pathway, dossier quality, and regulator questions.
- Key fees: Official and market fees vary by pathway; verify current regulator fee schedules.
- Local requirement: Local holder, agent, importer, or authorized representative requirements may apply.
- Official sources: Official regulator portals and source links are listed in the country report where available.
- Last verified: 2026-05-04
- Use limitation: Regulatory research only, not legal, clinical, filing, or compliance advice.
- Preferred citation: MedTech Atlas
Market Overview
- Market profile: Mexico is a core Latin American pharmaceutical market. COFEPRIS registration, public procurement, private pharmacy channels, and Spanish labeling are core barriers.
- Regulatory maturity: Medium-high. COFEPRIS regulates new medicines, generics, biotech products, and imported drugs.
- Core decision: Determine the Modalidad: domestic/foreign manufacturing, new molecule/generic, biotech innovator/biosimilar.
Regulator
- Authority: COFEPRIS
- Official portal: https://www.gob.mx/cofepris/acciones-y-programas/registro-sanitario-de-medicamentos-nuevos
Product Types and Review Pathways
| Type | COFEPRIS route |
|---|---|
| New molecule | Medicamento nuevo |
| Generic | Genérico |
| Biotech innovator | Biotecnológico innovador |
| Biosimilar | Biotecnológico biocomparable |
| Foreign-manufactured drug | Corresponding foreign manufacturing Modalidad |
Registration Pathway
During the limited-time free period, sign in or register to view the complete pharmaceutical country report.